Filing Flows › ResMed (RMD) › Q1 FY27 › vs Q4 FY26
ResMed (RMD) Q1 FY27 vs Q4 FY26 (quarter over quarter)
ResMed's revenue fell $48.8M (-3%) from $1.5B in Q4 FY26 to $1.4B in Q1 FY27. The biggest changes: Total Sleep and Breathing Health −$31.9M (-2%); Residential Care Software −$16.9M (-10%). Gross margin 61.5% against 58.8% (+2.7 pts).
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart draws each line against Q4 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q4 FY26 | Change | |
|---|---|---|---|
| Gross margin | 61.5% | 58.8% | +2.7 pts |
| Operating margin | 32.0% | 30.7% | +1.4 pts |
| Net margin | 29.6% | 26.2% | +3.4 pts |
| Free cash flow margin | 26.4% | 27.6% | -1.2 pts |
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Total Sleep and Breathing Health | $1.3B | $1.3B | −$31.9M | -2% |
| Residential Care Software | $155M | $172M | −$16.9M | -10% |
| Revenue | $1.4B | $1.5B | −$48.8M | -3% |
| Gross profit | $871M | $861M | $9.3M | +1% |
| Cost of revenue | $544M | $602M | −$58.2M | -10% |
| Other income, net | $86.2M | $25.5M | $60.7M | +239% |
| Operating profit | $453M | $449M | $4.3M | +1% |
| Operating expenses | $418M | $413M | $5.1M | +1% |
| Pre-tax earnings | $539M | $474M | $65.0M | +14% |
| Research & development | $103M | $106M | −$2.9M | -3% |
| SG&A | $315M | $296M | $18.4M | +6% |
| Net earnings | $418M | $383M | $35.0M | +9% |
| Income tax | $121M | $90.7M | $30.0M | +33% |
| Depreciation & amortization | $41.7M | $44.8M | −$3.0M | -7% |
| Share-based compensation | $29.5M | $27.5M | $2.0M | +7% |
| Working capital & other | $67.2M | $1.0M | $66.2M | 65× |
| Operating cash flow | $422M | $455M | −$32.2M | -7% |
| Free cash flow (OCF − capex) | $374M | $404M | −$29.8M | -7% |
| Capital expenditures | $48.7M | $51.1M | −$2.4M | -5% |
Questions
How much did ResMed's revenue grow quarter over quarter in Q1 FY27?
ResMed's revenue fell $48.8M (-3%) from $1.5B in Q4 FY26 to $1.4B in Q1 FY27.
What drove ResMed's revenue change in Q1 FY27?
Total Sleep and Breathing Health −$31.9M (-2%); Residential Care Software −$16.9M (-10%).